Research and development
Continually innovating to push the boundaries of human advancement in medicine
We are committed to investing broadly in innovation and development of best-in-class or first-in-class products and supporting technologies. Our current focus is within oncology and autoimmune disorders, but we also have activities within infectious diseases, primarily together with our partners.
Technology platform
Our core technology is the Nykode Technology platform, based on the concept of targeting antigen to Antigen Presenting Cells to create better vaccines.
Therapeutic areas
Our technology platform may benefit the lives of patients across several areas of high unmet need. Our pipeline is currently focused on cancer and autoimmune disorders, and we have some activities within infectious diseases, primarily together with our partners.
Scientific papers and presentations
See our latest scientific papers and presentations here
Scientific papers and presentations
